Clinical Trial

Evolut™ EXPAND TAVR II Pivotal Trial

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.
Protocol Amendment History 42 amendments
This ClinicalTrials.gov record has been amended 42 times since 2021-11-24; most recent amendment 2026-05-15.
Status change: Recruiting → Active, Not Recruiting 2025-09-11
Status change: Not Yet Recruiting → Recruiting 2022-06-03
Trial Details
NCT Number NCT05149755
Lead Sponsor Medtronic Cardiovascular
Conditions Moderate Aortic Valve Stenosis
Enrollment 650 participants
Start Date 2022-04-27
Primary Completion 2027-09 (estimated)
Study Completion 2034-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-19